1. First‐in‐Human Studies of MW01‐6‐189WH, a Brain‐Penetrant, Antineuroinflammatory Small‐Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers. Issue 2 (7th April 2020) Authors: Van Eldik, Linda J.; Sawaki, Lumy; Bowen, Karen; Laskowitz, Daniel T.; Noveck, Robert J.; Hauser, Byron; Jordan, Lynn; Spears, Tracy G.; Wu, Huali; Watt, Kevin; Raja, Shruti; Roy, Saktimayee M.; Watterson, D. Martin; Guptill, Jeffrey T. Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 2(2021) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗